Director - Professor Bruce Campbell
The Department of Neurology is recognised as one of the strongest in Australia and has international recognition for its work in stroke, epilepsy and multiple sclerosis in particular.
The Department has active research programs which augment each of the clinical, specialised programs undertaken by the department alone, and in conjunction with the Department of Neurosurgery.
The specialised clinical programs include:
Stroke, Epilepsy, Multiple Sclerosis, Parkinson’s Disease, Movement Disorders, Neuro-ocular disorders, Neurophysiology, Peripheral Neuropathy and specialised programs in neuroradiology and neurovascular.
Patients participating in research trials contribute to world leading programs in emergency stroke care and secondary prevention.
Research led by the Royal Melbourne Hospital team has changed practice in acute stroke therapies globally, including the introduction of endovascular clot retrieval as standard therapy and expansion of access to thrombolysis using advanced brain imaging to identify patients with salvageable brain tissue beyond 4.5h after stroke onset.
The Multiple Sclerosis Unit cares for approximately 471 patients with multiple sclerosis per year at The Royal Melbourne Hospital. Apart from the inpatient and outpatient care of patients with multiple sclerosis, the MS Unit has a major commitment to the conduct of randomised clinical trials of new medication and potential therapies for multiple sclerosis. This activity allows our patients access to the latest advances in therapy and keeps medical and nursing staff up-to-date with current trends. Most of the trials also have an MRI component which strengthens our links with the neuro-radiologists and Department of Radiology at The Royal Melbourne Hospital.
The RMH Dementia Research Unit runs a range of clinical trials that are particularly aimed at looking for gold standard pharmacological treatment approaches for various types of dementias. It is hoped that these studies will eventually lend towards the identification of drugs that can help to treat or delay the progression of dementia. Currently, the unit is actively recruiting participants for Alzheimer’s, Vascular and Fronto-temporal dementia studies. For further information regarding these studies, please refer to the RMH clinical trials website (filter by trial type: Dementia) or contact the team at DementiaTrials@thembc.org.au.
The Royal Melbourne Hospital Neuroscience Foundation
RMH Neuroscience Foundation
PO Box 2116
Royal Melbourne Hospital VIC 3050
In the spirit of reconciliation, the Royal Melbourne Hospital Neuroscience Foundation acknowledges the Kulin nations as the Traditional Custodians of the land on which our services are located. We are committed to improving the health and well-being of Aboriginal and Torres Strait Islander peoples, as with all Australians.